Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
Sarah A. Buchan, Hannah Chung, Kevin A. Brown, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2232760-e2232760
Open Access | Times Cited: 277

Showing 1-25 of 277 citing articles:

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 1, pp. 21-34
Open Access | Times Cited: 474
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 19, pp. 1804-1816
Open Access | Times Cited: 362
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 232
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022
Nana Wu, Keven Joyal‐Desmarais, Paula Aver Bretanha Ribeiro, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 5, pp. 439-452
Open Access | Times Cited: 187
Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity
Francesco Menegale, Mattia Manica, Agnese Zardini, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2310650-e2310650
Open Access | Times Cited: 175
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
Lamprini Veneti, Håkon Bøas, Anja Bråthen Kristoffersen, et al.
Eurosurveillance (2022) Vol. 27, Iss. 4
Open Access | Times Cited: 156
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study
Ramandip Grewal, Sophie A. Kitchen, Lena Nguyen, et al.
BMJ (2022), pp. e071502-e071502
Open Access | Times Cited: 141
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study
Sara Y. Tartof, Jeff Slezak, Laura Puzniak, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 7, pp. 689-699
Open Access | Times Cited: 133
Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study
Julia Stowe, Nick Andrews, Freja Kirsebom, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 130
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
Stijn P. Andeweg, Brechje de Gier, Dirk Eggink, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 118
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 105
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study
Katherine Adams, Jillian P. Rhoads, Diya Surie, et al.
BMJ (2022), pp. e072065-e072065
Open Access | Times Cited: 92
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice
Baoling Ying, Suzanne M. Scheaffer, Bradley Whitener, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1572-1587.e11
Open Access | Times Cited: 89
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age
Chandra J. Cohen-Stavi, Ori Magen, Noam Barda, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 3, pp. 227-236
Open Access | Times Cited: 87
Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study
Burc Barin, Ulus Kasap, Ferda Selçuk, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 4, pp. e274-e283
Open Access | Times Cited: 79
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization
Daniel R. Feikin, Laith J. Abu‐Raddad, Nick Andrews, et al.
Vaccine (2022) Vol. 40, Iss. 26, pp. 3516-3527
Open Access | Times Cited: 79
Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants
Clauber Henrique Souza da Costa, Camila Auad Beltrão de Freitas, Cláudio Nahum Alves, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 78
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
Marios Koutsakos, Arnold Reynaldi, Wen Shi Lee, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 879-892.e4
Open Access | Times Cited: 78
Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons
Chrispin Chaguza, Andreas Coppi, Rebecca Earnest, et al.
Med (2022) Vol. 3, Iss. 5, pp. 325-334.e4
Open Access | Times Cited: 72
Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study
Susana Monge, Ayelén Rojas‐Benedicto, Carmen Olmedo, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 9, pp. 1313-1320
Open Access | Times Cited: 72
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Effects of COVID‐19 vaccination during pregnancy on SARS‐CoV‐2 infection and maternal and neonatal outcomes: A systematic review and meta‐analysis
Masoud Rahmati, Dong Keon Yon, Seung Won Lee, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 3
Closed Access | Times Cited: 42
Primary assessment of the diversity of Omicron sublineages and the epidemiologic features of autumn/winter 2022 COVID-19 wave in Chinese mainland
Gang Lü, Yun Ling, Minghao Jiang, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 4, pp. 758-767
Open Access | Times Cited: 40
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Nature (2024) Vol. 630, Iss. 8018, pp. 950-960
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top